Gaia Coppock is a Nephrology physician affiliated with Penn Center for AIDS Research. OpenAlex indexes 27 publications with 1,454 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
1 Founders
Philadelphia, PA 19104
Telephone
215-662-2638Provider last certified this registry record 16 Jan 2020.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year202526 payments$24,069openpaymentsdata.cms.gov ↗
- Calliditas Therapeutics US Inc.Program year20251 payment
- Otsuka America Pharmaceutical, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.7%Loop diuretic16%Furosemide43%Torsemide31%Bumetanide26%Part D<11 patientsCalcium channel blocker10.5%Nifedipine Er57%Amlodipine Besylate43%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
25.4%Corticosteroid7.7%Prednisone100%Part D≥14 patientsSGLT2 inhibitor5.6%Farxiga64%Jardiance36%Part D<11 patients+ 3 more classes in this area
Other
4.1%Potassium Binder2.2%Sodium Polystyrene Sulfonate100%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.9%Lokelma100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pegcetacoplan Subcutaneous Infusion: Early Access and Patient Training
Journal of the American Society of Nephrology
2025 - Improving the Histological Classification of Diabetic Nephropathy Based on Transformative Research in Diabetic Nephropathy (TRIDENT)
Journal of the American Society of Nephrology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Charu Aggarwal, MD, MPH
Penn Center for AIDS Research
Janos Tanyi, MD
Penn Center for AIDS Research
Daniel Landsburg, MD
Penn Center for AIDS Research
Bryson Katona, MD, PhD
Penn Center for AIDS Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”